472 related articles for article (PubMed ID: 17459469)
1. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.
Agrawal P; Gupta U; Jain NK
Biomaterials; 2007 Aug; 28(22):3349-59. PubMed ID: 17459469
[TBL] [Abstract][Full Text] [Related]
2. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting.
Bhadra D; Yadav AK; Bhadra S; Jain NK
Int J Pharm; 2005 May; 295(1-2):221-33. PubMed ID: 15848007
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and gene delivery of poly-L-lysine octa(3-aminopropyl)silsesquioxane dendrimers: nanoglobular drug carriers with precisely defined molecular architectures.
Kaneshiro TL; Wang X; Lu ZR
Mol Pharm; 2007; 4(5):759-68. PubMed ID: 17705440
[TBL] [Abstract][Full Text] [Related]
4. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers.
Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK
Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354
[TBL] [Abstract][Full Text] [Related]
5. PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate.
Bhadra D; Bhadra S; Jain NK
Pharm Res; 2006 Mar; 23(3):623-33. PubMed ID: 16374532
[TBL] [Abstract][Full Text] [Related]
6. Pegylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether.
Bhadra D; Bhadra S; Jain NK
J Pharm Pharm Sci; 2005 Sep; 8(3):467-82. PubMed ID: 16401394
[TBL] [Abstract][Full Text] [Related]
7. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells.
Gupta U; Dwivedi SK; Bid HK; Konwar R; Jain NK
Int J Pharm; 2010 Jun; 393(1-2):185-96. PubMed ID: 20382210
[TBL] [Abstract][Full Text] [Related]
8. Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam.
Prajapati RN; Tekade RK; Gupta U; Gajbhiye V; Jain NK
Mol Pharm; 2009; 6(3):940-50. PubMed ID: 19231841
[TBL] [Abstract][Full Text] [Related]
9. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
Zhang XQ; Wang XL; Huang SW; Zhuo RX; Liu ZL; Mao HQ; Leong KW
Biomacromolecules; 2005; 6(1):341-50. PubMed ID: 15638538
[TBL] [Abstract][Full Text] [Related]
10. A facile synthesis and physical properties of nano-sized dendritic alpha,epsilon-poly(L-lysine)s for the delivery of nucleic acids.
Eom KD; Kim JS; Park SM; Kim MS; Yu R; Jung HM; Kim SG; Yoo H
J Nanosci Nanotechnol; 2006 Nov; 6(11):3532-8. PubMed ID: 17252805
[TBL] [Abstract][Full Text] [Related]
11. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
Singh P; Gupta U; Asthana A; Jain NK
Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
[TBL] [Abstract][Full Text] [Related]
12. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.
Nimje N; Agarwal A; Saraogi GK; Lariya N; Rai G; Agrawal H; Agrawal GP
J Drug Target; 2009 Dec; 17(10):777-87. PubMed ID: 19938949
[TBL] [Abstract][Full Text] [Related]
13. PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist.
Gajbhiye V; Vijayaraj Kumar P; Tekade RK; Jain NK
Eur J Med Chem; 2009 Mar; 44(3):1155-66. PubMed ID: 18760863
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and inhibition study on tripeptide inhibitor modified poly(L-lysine) dendrimers.
Zhang X; Luo K; Wang G; Nie Y; He B; Wu Y; Gu Z
J Biomater Appl; 2012 Jul; 27(1):17-26. PubMed ID: 21123282
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared spectroscopic study on guest-host interactions among G0-G7 amine-terminated poly(amidoamine) dendrimers and porous silica materials for simultaneously determining the molecular weight and particle diameter by multivariate calibration techniques.
Heigl N; Bachmann S; Petter CH; Marchetti-Deschmann M; Allmaier G; Bonn GK; Huck CW
Anal Chem; 2009 Jul; 81(14):5655-62. PubMed ID: 19601650
[TBL] [Abstract][Full Text] [Related]
16. HPLC separation of different generations of poly(amidoamine) dendrimers modified with various terminal groups.
Islam MT; Shi X; Balogh L; Baker JR
Anal Chem; 2005 Apr; 77(7):2063-70. PubMed ID: 15801739
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers.
Kaminskas LM; Kelly BD; McLeod VM; Boyd BJ; Krippner GY; Williams ED; Porter CJ
Mol Pharm; 2009; 6(4):1190-204. PubMed ID: 19453158
[TBL] [Abstract][Full Text] [Related]
18. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes.
Mishra V; Gupta U; Jain NK
Pharmazie; 2010 Dec; 65(12):891-5. PubMed ID: 21284258
[TBL] [Abstract][Full Text] [Related]
19. A novel poly(l-glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions.
Yuan H; Luo K; Lai Y; Pu Y; He B; Wang G; Wu Y; Gu Z
Mol Pharm; 2010 Aug; 7(4):953-62. PubMed ID: 20481567
[TBL] [Abstract][Full Text] [Related]
20. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
